Suppr超能文献

停用β受体阻滞剂和利尿剂的长期降压治疗后脂质代谢的正常化。

Normalization of lipid metabolism after withdrawal from antihypertensive long-term therapy with beta blockers and diuretics.

作者信息

Middeke M, Richter W O, Schwandt P, Beck B, Holzgreve H

机构信息

Medical Policlinic, University of Munich, FRG.

出版信息

Arteriosclerosis. 1990 Jan-Feb;10(1):145-7. doi: 10.1161/01.atv.10.1.145.

Abstract

Blood pressure and serum lipoprotein concentrations were assessed in 40 men with essential hypertension at the end of a long-term, controlled intervention study (HAPPHY) after 5.2 +/- 1.4 years of treatment with hydrochlorothiazide (n = 23) or atenolol (n = 17) and after a wash-out period. After withdrawal from antihypertensive medication, the blood pressures of patients treated with diuretics or beta blockers rose from 142/93 and 145/91 to 159/106 and 165/104 mm Hg, respectively. At the same time, low density lipoprotein cholesterol decreased by 17 and 12 mg/dl, respectively, in the diuretic and beta blocker groups (p less than 0.05). In addition, total cholesterol decreased by 16 mg/dl (p less than 0.05) in the diuretic group, whereas high density lipoprotein cholesterol increased by 8 mg/dl (p less than 0.01) and triglycerides decreased by 27 mg/dl (p less than 0.05) in the beta blocker group at the end of the wash-out period as compared to the final phase of the HAPPHY study. The data indicate the persistence of lipid changes during long-term treatment with hydrochlorothiazide and atenolol. For the first time, it was clearly demonstrated that the well-known unfavorable effects of diuretics and beta blockers on lipid metabolism are reversible after cessation of long-term therapy of several years' duration.

摘要

在一项长期对照干预研究(HAPPHY)结束时,对40名原发性高血压男性患者的血压和血清脂蛋白浓度进行了评估。这些患者分别接受了5.2±1.4年的氢氯噻嗪治疗(n = 23)或阿替洛尔治疗(n = 17),之后进入洗脱期。停用抗高血压药物后,接受利尿剂或β受体阻滞剂治疗的患者血压分别从142/93和145/91毫米汞柱升至159/106和165/104毫米汞柱。同时,利尿剂组和β受体阻滞剂组的低密度脂蛋白胆固醇分别下降了17毫克/分升和12毫克/分升(p<0.05)。此外,与HAPPHY研究的最后阶段相比,洗脱期结束时,利尿剂组的总胆固醇下降了16毫克/分升(p<0.05),而β受体阻滞剂组的高密度脂蛋白胆固醇升高了8毫克/分升(p<0.01),甘油三酯下降了27毫克/分升(p<0.05)。数据表明,氢氯噻嗪和阿替洛尔长期治疗期间脂质变化持续存在。首次明确证明,利尿剂和β受体阻滞剂对脂质代谢的众所周知的不利影响在数年的长期治疗停止后是可逆的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验